Stratec Se

Stratec Se ROA

The Return on Assets (ROA) of Stratec Se (SBS.DE) as of Oct 16, 2026 is -0.05 %. In the previous year, Return on Assets (ROA) was 3.60 % — a change of -101.52% (lower).

ROA

-0.05 %

YoY

-101.52%

Last updated:

In 2025, Stratec Se's return on assets (ROA) was -0.05 %, a -101.52% increase from the 3.60 % ROA in the previous year.

The Stratec Se ROA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROA
Date
ROA
Jan 1, 2018
3.26 EUR
Jan 1, 2019
4.82 EUR
Jan 1, 2020
7.59 EUR
Jan 1, 2021
10.84 EUR
Jan 1, 2022
7.35 EUR
Jan 1, 2023
3.29 EUR
Jan 1, 2024
3.60 EUR
Jan 1, 2025
-0.05 EUR
The Stratec Se ROA history
YEARROAYoY
-0.05 %-101.52%
3.60 %+9.28%
3.29 %-55.19%
7.35 %-32.20%
10.84 %+42.95%
7.59 %+57.28%
4.82 %+48.02%
3.26 %-66.48%
9.72 %+28.09%
7.59 %-45.40%
13.89 %-3.18%
14.35 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Stratec Se Stock analysis

What does Stratec Se do? The company Stratec SE is a German company operating in the medical technology industry. It was founded in 1984 and has since become a leading provider of automation solutions and diagnostic instruments. Stratec's business model is based on the development and production of devices and systems used in medical diagnostics. The company focuses in particular on the areas of immunology, clinical chemistry, and hematology. Stratec also offers innovative solutions in microscopy and cell analysis. In the "automation solutions" division, Stratec develops systems for the automation of laboratory processes. These are mainly used in clinical diagnostics to accelerate and simplify workflow. Examples include sample identification systems, pipetting robots, and analysis devices. In the "in vitro diagnostics" division, Stratec offers products for determining blood values. This includes devices for determining glucose, cholesterol, and hemoglobin levels, as well as devices for infection diagnostics and tumor and allergy diagnostics. Another division of Stratec is "microscopy." The company manufactures automated microscope systems, primarily used in biomedical research to analyze cells and tissues. In the "cell analysis" division, Stratec offers innovative methods for analyzing cells, such as cell growth and vitality determination. Stratec always focuses on tailoring the design of its products to the needs of its customers. High flexibility in device development and manufacturing is therefore an important factor in the company's success. In addition to device development and production, Stratec also provides services related to its products. These include installation, maintenance, and on-site repair of devices for customers. Stratec SE operates internationally and has branches in Europe, Asia, and America. The company employs over 1,000 people worldwide. Overall, Stratec SE is a successful and renowned provider of medical devices and systems for automating laboratory processes. With its diverse product portfolio and high flexibility in customer support, Stratec has earned a leading position in the industry. Stratec Se is one of the most popular companies on Eulerpool.

ROA Details

Understanding Stratec Se's Return on Assets (ROA)

Stratec Se's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Stratec Se's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Stratec Se's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Stratec Se’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Stratec Se stock

Return on Assets (ROA) of Stratec Se is -0.05 % in 2025.

Return on Assets (ROA) of Stratec Se changed from 3.60 % to -0.05 %, representing a -101.52% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Assets (ROA) Stratec Se since 2006 – with annual values, charts, and detailed analysis.

Return on Assets, also known as ROA, is a financial metric used to measure a company's profitability. It is used to determine how effectively a company uses its assets to generate profits. It is also referred to as the ratio of net income to total assets. ROA is an important indicator of a company's overall financial performance as it measures the company's ability to generate more profit from the assets it employs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Assets (ROA)'s Stratec Se with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Assets (ROA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Assets (ROA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Stratec Se

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Stratec Se